Phase I trial of gemcitabine and carboplatin in metastatic non-small-cell lung cancer: a Groupe Français de Pneumo-Cancérologie Study. [electronic resource]
Producer: 20020708Description: 191-8 p. digitalISSN:- 0169-5002
- Adult
- Aged
- Anemia -- chemically induced
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Carboplatin -- administration & dosage
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Deoxycytidine -- administration & dosage
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Fever -- chemically induced
- Follow-Up Studies
- Humans
- Infusions, Intravenous
- Lung Neoplasms -- drug therapy
- Male
- Maximum Tolerated Dose
- Middle Aged
- Neutropenia -- chemically induced
- Platelet Count
- Thrombocytopenia -- chemically induced
- Vomiting -- chemically induced
- Gemcitabine
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.